| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_72402cae30ff8060e534cb12ac2d080f |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07B2200-05 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D417-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D413-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07B59-002
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D403-04 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D403-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D417-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D413-04 |
| filingDate |
2015-11-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2016-08-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d091dd6884a6cafbbad506d215942973
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_deaafc2accf05d22f85c6d2dfe765a6b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f826452ebab32d498176dc199c9c1700
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4f4eb9e0f9468a6638d5c4b8e3e76068
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f93caed19186a3c9854631638c862346
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5f4f63526c9cfff10b0d4eed65613a80
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_471e883e4e1b099be66e346cdfcf4c8d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_39a74dcd8ba092e78d99eb3c91406c11 |
| publicationDate |
2016-08-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-9403806-B1 |
| titleOfInvention |
Cognition enhancing compounds and compositions, methods of making, and methods of treating |
| abstract |
The invention relates generally to muscarinic agonists, which are useful for stimulating muscarine receptors, and treating cognitive disorders. Included among the muscarinic agonists disclosed herein are oxadiazole derivatives, compositions, and preparations thereof. Methods of synthesizing oxadiazole compounds also are provided. This disclosure also relates in part to compositions for enhancing cognitive function in subjects such as humans, the compositions comprising a muscarinic agonist or a pharmaceutically suitable form thereof. This disclosure relates in part to methods of treating animals such as humans by administering such compositions. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/LT-4963-B
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/LT-5030-B
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2017313687-A1 |
| priorityDate |
2010-09-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |